Hungary's Richter buys minority stake in U.S. company

Via convertible notes.

Hungary Richter to pay HUF 100 dividend per share

From 2018 profits. Invitation for AGM shows.

Homeopathy is ineffective, pharmacies need to inform buyers in Hungary

Life is hard.

Hungary Richter quarterly profit plummets

One-off item dents profits.

Change in the executive management of Hungary's Richter

New technical director to be appointed.

Egis expands is plant in Körmend Hungary

With EUR 25 million investment.

Hungary Richter reports double-digit drop in Q3 after-tax profit

Drop in Esmya sales weigh on results.

Hungary's Richter receives good news

Pharmafarm is back in business.

Hungary's Richter to sell new drug in EU

Signs license and distribution agreement.

Hungary Richter adds new item to product line

Women's Healthcare portfolio expanded.

Hungary Richter seen reporting profit boom for Q2

There are some crucial questions, though.

Hungary Richter buys intellectual property rights

For drug launch in the United States.

Romanian wholesaler of Hungary's Richter suspended

Hungary's leading pharma company reacts.

ANALYST VIEW - Jefferies lowers target price for Hungary's Richter

To HUF 5,470 from HUF 5,695.

ANALYST VIEW - Hungary's Richter gets 'Hold' rating from Jefferies

After release of Q1 earnings report.

Hungary pharma Richter posts record-low profit over Esmya

Good news about flagship product of Hungary's Richter

Share price on the rise.

Richter drug wins 2017 Innovation Grand Prize in Hungary

Richter awarded for Cariprazine.

Hungary Richter gets good news about product

European Medicines Agency is not a bearer of bad news only.

ANALYST VIEW - Jefferies downgrades Hungary's Richter over Esmya woes

Slashes target price, removes Esmya from model.